Impact of baseline clinical features on outcomes of nebulized glycopyrrolate therapy in COPD
Abstract Inhaled bronchodilators are central for the treatment of chronic obstructive pulmonary disease (COPD), as they can provide symptom relief and reduce the frequency and severity of exacerbations while improving health status and exercise tolerance. In 2017, glycopyrrolate (GLY) delivered via...
Guardado en:
Autores principales: | Donald P. Tashkin, Xiaoli Niu, Sanjay Sharma, Shahin Sanjar |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/34def7afb7e54f30b071260caa02f52c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Clinical characteristics and factors associated with triple therapy use in newly diagnosed patients with COPD
por: Mònica Monteagudo, et al.
Publicado: (2021) -
Feasibility and applicability of the paper and electronic COPD assessment test (CAT) and the clinical COPD questionnaire (CCQ) in primary care: a clinimetric study
por: J. W. H. Kocks, et al.
Publicado: (2017) -
Mepolizumab and COPD in Real Life
por: Fernando Revuelta-Salgado, et al.
Publicado: (2022) -
Correction to: Measuring disease activity in COPD: is clinically important deterioration the answer?
por: Dave Singh, et al.
Publicado: (2021) -
Blood Eosinophils and Pulmonary Rehabilitation in COPD
por: Jafar Aljazeeri, et al.
Publicado: (2021)